Versor Investments LP 13D and 13G filings for Intersect ENT, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:21 pm Sale | 2022-12-31 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 0 0.000% | -3,347,165 (Position Closed) | Filing |
| 2022-02-23 08:56 am Sale | 2022-02-14 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 3,347,165 10.000% | -21,926 (-0.65%) | Filing |
| 2022-02-17 11:40 am Purchase | 2022-02-07 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 3,369,091 10.070% | 193,994 (+6.11%) | Filing |
| 2022-02-08 11:14 am Purchase | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 3,175,097 9.500% | 1,439,018 (+82.89%) | Filing |
| 2021-08-17 3:21 pm Purchase | 2021-08-09 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 1,736,079 5.210% | 1,736,079 (New Position) | Filing |